Crossmark

Acquired cancer tyrosine kinase inhibitor resistance: ROS as critical determinants

Crossref DOI link: https://doi.org/10.1038/s41392-021-00844-5

Published Online: 2021-12-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bekeschus, Sander https://orcid.org/0000-0002-8773-8862
License Information

Text and Data Mining valid from 2021-12-24

Version of Record valid from 2021-12-24
More Information

Article History

Received: 1 October 2021

Revised: 8 November 2021

Accepted: 30 November 2021

First Online: 24 December 2021

Competing interests

: The author declares no competing interests.